Stay updated on PHA-022121 Dose Study for Acute Angioedema Clinical Trial
Sign up to get notified when there's something new on the PHA-022121 Dose Study for Acute Angioedema Clinical Trial page.

Latest updates to the PHA-022121 Dose Study for Acute Angioedema Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.3.2 replaces v3.3.1 on the site, reflecting a minor platform update and screenshot refresh. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoChange DetectedRevision: v3.3.1 was added and Revision: v3.2.0 was removed in the Record History; this change updates only version labels in the history list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedNew sections for Outcome Measures (Results) and Participant Flow were added to the record history, with Study Status updates and a QC status in the 2025-10-24 and 2025-11-07 versions.SummaryDifference0.8%

- Check35 days agoChange DetectedAn additional version entry appears in the Record History page for NCT04618211; there are no substantive changes to the study content, status, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedSummary of changes: Added a government-operating-status notice and a new study-related section with dates and outcomes, plus a new revision tag (v3.2.0). Removed the older revision tag (v3.1.0).SummaryDifference12%

- Check71 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.2%

Stay in the know with updates to PHA-022121 Dose Study for Acute Angioedema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PHA-022121 Dose Study for Acute Angioedema Clinical Trial page.